COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
作者信息
Movahedi Nasim, Ziaee Vahid
机构信息
Children's Medical Center, Pediatrics Center of Excellence, Tehran, Iran.
Department of Pediatrics, Tehran University of Medical Science, Tehran, Iran.
出版信息
Pediatr Rheumatol Online J. 2021 Jun 10;19(1):86. doi: 10.1186/s12969-021-00570-w.
Abstract
摘要
相似文献
1
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
Pediatr Rheumatol Online J. 2021 Jun 10;19(1):86. doi: 10.1186/s12969-021-00570-w.
2
COVID-19-associated myositis may be dermatomyositis.
Muscle Nerve. 2021 Jan;63(1):E9-E10. doi: 10.1002/mus.27105. Epub 2020 Nov 15.
3
Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis.
Acta Derm Venereol. 2020 Aug 18;100(15):adv00238. doi: 10.2340/00015555-3594.
4
Diagnosis and treatment of polymyositis and dermatomyositis.
Compr Ther. 1990 Apr;16(4):16-24.
5
Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits.
Expert Rev Clin Immunol. 2022 Apr;18(4):413-423. doi: 10.1080/1744666X.2022.2054803. Epub 2022 Mar 27.
6
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222.
7
[Dermatomyositis and polymyositis].
Med Welt. 1972 Jan 15;23(3):77-8.
8
[Polymyositis--dermatomyositis: advances in diagnosis and therapy].
Przegl Lek. 1987;44(3):345-50.
9
[Antinuclear and anticytoplasmic antibodies in polymyositis and dermatomyositis].
Nihon Naika Gakkai Zasshi. 1986 Nov;75(11):1597-601. doi: 10.2169/naika.75.1597.
10
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22.
引用本文的文献
1
Severe Post-Viral Polymyositis after COVID-19 in Childhood: A Case Report and Literature Review.
Children (Basel). 2024 Aug 20;11(8):1011. doi: 10.3390/children11081011.
2
Epidemiology of the idiopathic inflammatory myopathies.
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
3
The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies.
Pediatr Rheumatol Online J. 2023 Sep 12;21(1):100. doi: 10.1186/s12969-023-00873-0.
4
Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies.
Pediatr Rheumatol Online J. 2023 Aug 11;21(1):82. doi: 10.1186/s12969-023-00861-4.
5
Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children.
Int J Mol Sci. 2023 Jun 29;24(13):10874. doi: 10.3390/ijms241310874.
6
Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain.
Phys Med Rehabil Clin N Am. 2023 Aug;34(3):585-605. doi: 10.1016/j.pmr.2023.04.008. Epub 2023 Apr 14.
7
COVID-19 musculoskeletal involvement in children.
Front Pediatr. 2023 May 19;11:1200877. doi: 10.3389/fped.2023.1200877. eCollection 2023.
8
Case report: Unusual patient with dermatomyositis associated with SARS-CoV-2 infection.
Front Neurol. 2023 May 19;14:1122475. doi: 10.3389/fneur.2023.1122475. eCollection 2023.
9
Post-COVID-19 Polymyositis: A Case Report.
Cureus. 2022 Nov 1;14(11):e30991. doi: 10.7759/cureus.30991. eCollection 2022 Nov.
10
A case series of dermatomyositis following SARS-CoV-2 vaccination.
Front Med (Lausanne). 2022 Nov 7;9:1013378. doi: 10.3389/fmed.2022.1013378. eCollection 2022.
本文引用的文献
1
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
N Engl J Med. 2020 Dec 10;383(24):2389-2390. doi: 10.1056/NEJMc2031085. Epub 2020 Nov 20.
2
Dermatomyositis during COVID-19 Pandemic (A Case Series): Is there a Cause Effect Relationship?
J Assoc Physicians India. 2020 Nov;68(11):20-24.
3
COVID-19-associated myositis may be dermatomyositis.
Muscle Nerve. 2021 Jan;63(1):E9-E10. doi: 10.1002/mus.27105. Epub 2020 Nov 15.
4
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
Epidemiol Infect. 2020 Aug 28;148:e196. doi: 10.1017/S095026882000196X.
5
Myositis as a manifestation of SARS-CoV-2.
Ann Rheum Dis. 2021 Mar;80(3):e42. doi: 10.1136/annrheumdis-2020-217573. Epub 2020 Apr 23.
6
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
7
Influenza-associated myositis in children.
Infection. 2004 Aug;32(4):199-203. doi: 10.1007/s15010-004-4003-2.
Zotero 插件